Hyderabad Pharma Export Readiness Report 2026
Made in Hyderabad. Invisible to the world.

What 82 Hyderabad pharma exporters look like to a US buyer, and what to fix first.
Hyderabad makes medicines for the world. The city's API makers, CDMOs and CROs hold USFDA and EU approvals, run large reactor capacity and ship to regulated markets every week.
Online, most of that is hard to find. We scored 82 Hyderabad pharma exporters the way an overseas procurement head would before a first call. The average score was 37 out of 100. Not one company reached export-ready.
This isn't about plant quality. It's about what a buyer can see from 8,000 miles away, and right now most Hyderabad exporters are showing them far less than they have.

How we checked
Between October and November 2026 we reviewed 167 Hyderabad pharma companies. We left out large groups, foreign-owned subsidiaries, traders and companies with no export focus, and fully scored 82 small and mid-sized exporters.
We used only what a buyer can see from outside: the company website on desktop and phone, public USFDA, EDQM and EudraGMDP records, US Google searches, and LinkedIn. Each company was scored 0 to 10 on ten checks:
First impression: does the homepage say what you make, and for whom?
Regulatory proof: approvals by site, inspection years, DMF and CEP counts
Capability and capacity: reactor volume, scale, chemistries
Product portfolio: molecule names, CAS numbers, filing status
Quality and compliance story
Buyer path: an RFQ form and a named BD contact
Search visibility for your name and key molecules
LinkedIn company page
Leadership and BD visibility
Trust content: dated news, case studies, technical notes
Regulatory proof and capacity count double, because they are a buyer's first filter. The total is scaled to 100: 80 and above is export-ready, 60 to 79 credible with gaps, 40 to 59 at risk, and under 40 invisible.
What we found
The average score was 36.8 out of 100. Almost two in three companies scored under 40, and the best scored 62. Nine more couldn't be scored at all, because a buyer couldn't open their website.
The picture varies by segment. CDMOs and CROs, which sell services to Western sponsors, average 45. API and intermediates makers, the largest and most export-dependent group, average just 34.

The five gaps buyers notice first
Approvals with no proof behind them. A strip of USFDA, EU-GMP and WHO logos, but no site names, inspection years or DMF and CEP counts. Buyers can't verify a logo.
No capacity numbers. "State-of-the-art facility" instead of reactor volume per site. A buyer needs to know whether you can make their molecule at their scale.
Products listed as categories. Sourcing teams search by molecule and CAS number. "Cardiovascular APIs" won't be found.
No one to talk to. An info@ address and a generic form, with no named BD contact for the US or Europe.
Nothing recent. No dated news, old copyright years, no case studies. A site that looks inactive makes a buyer wonder whether the company is.

Why this matters now
US and European buyers are actively looking for new and backup suppliers, and India is high on their list. Their shortlists start online, often before anyone picks up the phone. A buyer who can't confirm your approvals, capacity and products in a few minutes doesn't send you an RFQ, and you never hear about the opportunity you lost.
Many Hyderabad exporters meet overseas buyers at trade fairs such as CPHI and iPHEX. But those meetings don't end at the booth: the buyer checks your website before following up. If the site doesn't back up the conversation, the money spent on the stand goes to waste.
A 30-day fix list
Rewrite the homepage headline to say what you make and for whom.
Add a regulatory page: each approval by site, with the last inspection year and DMF/CEP counts.
Publish capacity per site: reactor volume, scale range, key chemistries, real plant photos.
Turn your product list into a table with molecule names, CAS numbers and filing status.
Name a BD contact for the US and Europe, add an RFQ form and state your response time.
Post your latest approval or expansion as dated news, and link your LinkedIn page.
On our scale, bringing a company's three weakest checks up to a solid 7 out of 10 would add a median of 16 points. Same plant, same products: only what buyers can see changes.
Find out your score
If you're a promoter, BD head or export head at a Hyderabad API, CDMO, CRDMO or CRO company, we'll send you a free three-page Export Readiness Scorecard: your score, where buyers are likely to drop off, and three fixes you can make in the next 30 days, with or without us.
Write to sujal@onepoint61.in or call +91 81424 33161.
This review looks only at what a buyer can see online. It says nothing about plant quality, product quality or compliance. Individual scores are shared only with the company concerned.



Comments